|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,481 INR | +0.68% |
|
+3.21% | -0.70% |
AstraZeneca Pharma India Limited reported earnings results for the full year ended March 31, 2023. For the full year, the company reported sales was INR 10,029.71 million compared to INR 8,056 million a year ago. Revenue was INR 10,290.73 million compared to INR 8,203.58 million a year ago.
Net income was INR 992.93 million compared to INR 615.93 million a year ago. Basic earnings per share from continuing operations was INR 39.72 compared to INR 24.64 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -0.70% | 1.63B | |
| +31.37% | 588B | |
| -2.60% | 364B | |
| +20.83% | 326B | |
| +5.69% | 285B | |
| +14.83% | 239B | |
| +9.93% | 210B | |
| -6.95% | 200B | |
| +10.77% | 167B | |
| +0.10% | 161B |
ASTRAZENECA PHARMA INDIA LIMITED 
